NCT03511534View on ClinicalTrials.gov

Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 23, 2017

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
OCD
Interventions
BEHAVIORAL

Psychotherapy

Evidenced based psychotherapy by a trained psychologist

OTHER

Pharmacotherapy

Pharmacotherapy by a psychiatrist

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03511534 - Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder | Biotech Hunter | Biotech Hunter